RE:RE:RE:when there is fear and blood on the street you buy....Stop dreaming... What you are buying in AMCO and its growth at 8 % is spectecular. You are buying a orphan drugs that could itself be 500 million $ revenue generating assets eventually.
Concordia North America still generates at least 200 million -300 million in revenue alone..
Donnatal was bought for 200 million + concordia shares In 2014. The revenue generation is much higher now..Lanoxin and other drugs are doing well right now..Yes 2016 revenue is comparable to 2015 revenue, but over the past 3 years the revenue has jumped every year. There was a reason why market was giving them 100 $ a share valuation ...The current valuation is beyond stupidity..